Semaglutide effects people report and studies confirm

What Semaglutide effects may feel like

Semaglutide can lower hunger, weight, and blood sugar, and you'll see both the possible help and the risks, from what people felt to harms found in studies or on drug labels.

A common good report is relief from constant thoughts about food. People often call this "food noise." They may also report weight loss and fewer urges to eat. Common bad reports include nausea, foul burps, bowel trouble, and low energy. These problems often begin at the start or when a person gets more medicine.

If we were talking at the table, I'd draw one firm line. A person's story may give you a useful question for your doctor. It doesn't show that Semaglutide caused the change. The later warnings come from trials and safety reports. The page can't set a dose or personal care plan.

What people say Semaglutide changed for them

These are things people using Semaglutide have told one another. No controlled study has tested the claims, and no report is tied to a set dose.

Changes people welcome

• Hunger fades and "food noise" quiets (often reported). You'll hear this report most. Some notice it in week one or week two. They may feel full after eating between a third and half of their former serving. When the meal ends, they aren't already thinking about the next one. Many call that quiet the biggest change.
• Sweets and greasy food lose their pull (often reported). Rich or fried food may stop looking good and may bring on nausea. During the first weeks, some found themselves choosing produce or plainer food without much effort.
• Weight comes down (often reported). Accounts describe pounds coming off each month before the pace slows. People usually credit smaller meals, not added exercise.
• Blood-test numbers improve (commonly reported). People with type 2 diabetes often say morning sugar fell. They also mention improvement in the blood test that reflects usual sugar over time. Some say they didn't feel as many swings in energy.
• Alcohol sounds less appealing (reported now and then). As food urges ease, some say drinking stopped appealing. A few say the desire vanished. The semaglutide and alcohol page covers the early trial. Personal accounts can't prove a benefit.

Changes people don't welcome

• Nausea and sometimes vomiting (often reported). Roughly a third mention nausea, and a smaller group vomits. People often describe the start or an amount increase as the hardest stretch. The trouble may settle, then come back after a large or fatty meal. Some put the quiet spell at a week or two. Light meals and more water helped them.
• Sulfur or rotten-egg burps (commonly reported). The smell may start after an increase. It may last hours or even weeks, while bloating may bring a stuck-food feeling. The odor is hard to hide, though it may ease later.
• Constipation and diarrhea (commonly reported). Either may occur, and one person may swing between them. With constipation, hard stools may come less often. Some use a laxative. Loose stools may follow a dose or rich food. Eating hardly anything may worsen constipation too.
• Heartburn (reported now and then). People mention burning, repeated burps, and belly pressure. A few call it the worst heartburn they've felt. It may flare as the amount rises.
• Low energy at first (commonly reported). Some feel worn out for two days after the shot or during the early weeks. They often say energy comes back later.
• Food, tastes, or smells turn unpleasant (reported now and then). Meat, fried food, or fatty meals may suddenly seem awful. A metal taste may appear. Strong smells can bring on nausea. For a few people, appetite drops so far that meals slip their mind.
• A hollower face and more shedding (sometimes reported). A smaller group notices hair coming out after several months or sees a hollow face. They tend to blame the speed of lost pounds, not harm to hair or skin. They usually say the hair change is short-lived.
• Headache or dizziness (reported now and then). These may begin after the amount changes. Many tie them to skipped meals or a day when they hadn't drunk enough. Some say water helped.
• Soreness where the shot went in (sometimes reported). You may hear of mild itching, a small bump, tenderness, or red skin. People usually say it clears soon.

What Semaglutide side effects and warnings mean for you

The warnings below come from trials, labels, or reports filed after approval. You'll be able to give them more weight than the personal stories above.

Semaglutide side effects

Most semaglutide side effects affect digestion. Studies often found nausea, vomiting, loose stools, or constipation. Most problems didn't last and were mild or moderate. They became more common as the amount went up ^[16]. Nausea reached roughly one-third in one review. Later reports also centered on digestive trouble ^[5][18]. When food stays longer in your stomach, the problems fit the medicine's action ^[16].

A warning about one thyroid cancer. Semaglutide belongs to the GLP-1 group, meaning medicines that mimic a gut hormone. Large amounts caused one kind of thyroid tumor in rats and mice, but studies haven't clearly tied the same cancer to people taking Semaglutide. The label still rules out medullary thyroid cancer, a rare cancer starting in hormone-making thyroid cells. MEN-2 is also ruled out; this rare family disease may bring tumors in more than one gland ^[17][5]. Not every thyroid problem counts. You'll need the exact diagnosis for yourself or your relative.

Sudden pancreas swelling. Doctors call it pancreatitis, and it can hurt badly. This group of medicines carries a warning for it. A doctor may stop the medicine if this problem is suspected. Because very few cases occurred, a safety review couldn't settle the question of pancreatic cancer ^[5]. You have a warning here, not proof of cancer.

Gallstones or gallbladder illness. Compared with a drug-free shot, Semaglutide brought more gallstones in a safety review. The rise may largely follow a sharp drop in weight. Still, both trials and later reports found it ^[5]. Make sure your doctor hears about any past gallbladder trouble.

Diabetic eye disease worsening at first. SUSTAIN-6, a diabetes study, counted more eye trouble with Semaglutide. The standard 95% study check still showed a rise, so normal doubt didn't erase the eye finding. The trouble fell mainly on people whose diabetic eye disease was present before their sugar dropped fast. Your doctor may choose closer eye checks as sugar falls ^[2][5].

Some muscle leaves with fat. A small scan study found muscle among the lost tissue ^[13]. You have more reason to care as you age because age already thins muscle. The scans showed lost muscle, but they didn't test weakness or daily tasks. The muscle-loss page explains what remains unknown.

Weight returning after treatment stops. In the STEP 1 follow-up, people regained about 11.6 percentage points of starting body weight within a year ^[19]. Percentage points here means part of their weight before treatment, not part of the pounds they had lost. In STEP 4, regain also appeared when the study moved people to placebo ^[20]. Semaglutide looks more like continuing care than a cure. The studies don't tell you how long your care may last.

Hair shedding after quick weight loss. Reports about Semaglutide and tirzepatide raised concern over hair loss ^[14]. A different study found more shedding when weight fell faster and farther ^[15]. Hair often returns. This fits the body's response to fast loss better than direct injury to a hair root. If it happens, a doctor can search for a different cause.

Pregnancy. During pregnancy, the label bars Semaglutide. About half stays in the body for one week, while only a trace is there at five weeks. For a planned pregnancy, the label sets the stop date far earlier, often about two months ^[11]. You can't safely pick that date without your doctor.

Other pills while the amount rises. A slower stomach can delay another pill from entering your blood. One review found little serious harm from medicine pairings. It still called for close checks when a pill allows little error in its blood level ^[22]. The review doesn't supply a handy list. Bring your regular pill list to a doctor or pharmacist so they can identify any concern.

What Semaglutide gained approval to treat

Semaglutide is fairly new. Approval for type 2 diabetes came in 2017. A daily tablet followed in 2019-2020. Long-term weight care gained approval in 2021 ^[1][11].

A heart study reported its finding in 2023 ^[3]. A kidney study followed in 2024 ^[6]. Heart and long-term kidney uses then gained approval during 2024-2025. Approval for a serious fatty-liver disease followed in 2025.

From about 2022 through early 2025, a federal shortage allowed some pharmacies to make custom batches. This is called compounding. Officials ended the shortage early in 2025, and that allowance narrowed ^[11]. If you're considering a compounded form, you'll need to check the current rule.